Arrowstreet Capital, Limited Partnership Summit Therapeutics Inc. Transaction History

Arrowstreet Capital, Limited Partnership

  • $121 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.39 - $10.92 $338,615 - $1.55 Million
141,680 New
141,680 $1.11 Million
Q4 2021

Feb 14, 2022
SELL
$2.45 - $5.64 $35,304 - $81,272
-14,410 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$4.83 - $8.27 $61,775 - $105,773
-12,790 Reduced 47.02%
14,410 $72,000
Q2 2021

Aug 13, 2021
BUY
$5.15 - $8.46 $140,080 - $230,112
27,200 New
27,200 $203,000

Others Institutions Holding SMMT

# of Institutions
192
Shares Held
75.8M
Call Options Held
2.01M
Put Options Held
2.84M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.6B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email